[HTML][HTML] Particle detection and characterization for biopharmaceutical applications: current principles of established and alternative techniques
J Gross-Rother, M Blech, E Preis, U Bakowsky… - Pharmaceutics, 2020 - mdpi.com
Detection and characterization of particles in the visible and subvisible size range is critical
in many fields of industrial research. Commercial particle analysis systems have proliferated …
in many fields of industrial research. Commercial particle analysis systems have proliferated …
[HTML][HTML] Particles in biopharmaceutical formulations, part 2: an update on analytical techniques and applications for therapeutic proteins, viruses, vaccines and cells
A Roesch, S Zölls, D Stadler, C Helbig… - Journal of …, 2022 - Elsevier
Particles in biopharmaceutical formulations remain a hot topic in drug product development.
With new product classes emerging it is crucial to discriminate particulate active …
With new product classes emerging it is crucial to discriminate particulate active …
Evaluation of glass delamination risk in pharmaceutical 10 mL/10R vials
Glass delamination is characterized by the dissociation of glass flakes from the glass
surface. Since glass delamination is time dependent, 5 vial types were investigated to …
surface. Since glass delamination is time dependent, 5 vial types were investigated to …
Visible particle identification using Raman spectroscopy and machine learning
H Sheng, Y Zhao, X Long, L Chen, B Li, Y Fei, L Mi… - AAPS …, 2022 - Springer
Visible particle identification is a crucial prerequisite step for process improvement and
control during the manufacturing of injectable biotherapeutic drug products. Raman …
control during the manufacturing of injectable biotherapeutic drug products. Raman …
Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials
Y Nashed-Samuel, J Gastwirt, RB Kotia… - Journal of …, 2022 - Elsevier
A new type of lamellae-like particles was observed in protein based liquid therapeutic
protein drug product (DP) packaged in standard (STD) and delamination controlled (DC) …
protein drug product (DP) packaged in standard (STD) and delamination controlled (DC) …
Glass containers for parenteral products
R Swift, R Schaut, CR Flynn… - Parenteral Medications …, 2019 - taylorfrancis.com
This chapter discusses the important elements of extractables and leachables, with which
those in the pharmaceutical industry should be familiar. Drug products, biological products …
those in the pharmaceutical industry should be familiar. Drug products, biological products …
Characterization of a novel particle in a pharmaceutical drug product
S Moore, P Masatani, Y Nashed-Samuel… - PDA Journal of …, 2023 - journal.pda.org
A previously unreported particle type was observed during routine visual vial inspection of a
liquid drug product and suspected to be the result of vial delamination. Delamination is the …
liquid drug product and suspected to be the result of vial delamination. Delamination is the …
Parenteral container closure systems
R Mathaes, A Streubel - Challenges in Protein Product Development, 2018 - Springer
Parenteral container closure systems are in direct contact with the drug product formulation
and can significantly impact the product quality. The interaction between the drug product …
and can significantly impact the product quality. The interaction between the drug product …
Chemical Durability of Glass—Delamination
H Roehl, P Lam, D Ditter - Challenges in Protein Product Development, 2018 - Springer
Primary packaging containers used for the storage of parenteral drugs are designed to
protect the medicinal product from the environment to ensure patient safety. Mainly …
protect the medicinal product from the environment to ensure patient safety. Mainly …
Application of formulation principles to stability issues encountered during processing, manufacturing, and storage of drug substance and drug product protein …
S Vitharana, JM Stillahn, DS Katayama… - Journal of …, 2023 - Elsevier
The field of formulation and stabilization of protein therapeutics has become rather
extensive. However, most of the focus has been on stabilization of the final drug product …
extensive. However, most of the focus has been on stabilization of the final drug product …